Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: A mini review

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a new type of oral hypoglycaemic agent with good cardiovascular protective effects. There are several lines of clinical evidence suggest that SGLT2i can significantly reduce the risks of heart failure, cardiovascular death, and delay the progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jinchun, Liu, Yanmin, Wei, Xiaojuan, Zhang, Xiaofei, Ye, Yi, Li, Wei, Su, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393294/
https://www.ncbi.nlm.nih.gov/pubmed/36003915
http://dx.doi.org/10.3389/fcvm.2022.915455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393294/
https://www.ncbi.nlm.nih.gov/pubmed/36003915
http://dx.doi.org/10.3389/fcvm.2022.915455

Ejemplares similares